Elinx (ELNX) Stock Price

Elinx Price

OTC·CLOSED
0.00USD+0.00 (+0.00 %)
Market closed

Revenue has compounded at 90.2% per year over the past 4 years to 746,000.00 USD. Elinx's net margin stands at -93.9%, up from -10,556.1% several years earlier.

Elinx stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Elinx over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Elinx stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Elinx's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Elinx Stock Price History
DateElinx Price
8/4/20260.00 USD
8/3/20260.00 USD
7/30/20260.00 USD
7/29/20260.00 USD
7/28/20260.00 USD
7/27/20260.00 USD
7/24/20260.00 USD
7/23/20260.00 USD
7/22/20260.00 USD
7/21/20260.00 USD
7/20/20260.00 USD
7/17/20260.00 USD
7/16/20260.00 USD
7/15/20260.00 USD
7/14/20260.00 USD
7/13/20260.00 USD
7/10/20260.00 USD
7/9/20260.00 USD
7/8/20260.00 USD
7/7/20260.00 USD
7/6/20260.00 USD
7/2/20260.00 USD
7/1/20260.00 USD
6/30/20260.00 USD
6/29/20260.00 USD
6/26/20260.00 USD
6/25/20260.00 USD
6/24/20260.00 USD
6/23/20260.00 USD
6/22/20260.00 USD
6/18/20260.00 USD
6/17/20260.00 USD
6/16/20260.00 USD
6/15/20260.00 USD
6/12/20260.00 USD
6/11/20260.00 USD
6/10/20260.00 USD
6/9/20260.00 USD
6/8/20260.00 USD
6/5/20260.00 USD
6/4/20260.00 USD
6/3/20260.00 USD
6/2/20260.00 USD
6/1/20260.00 USD
5/29/20260.00 USD
5/28/20260.00 USD
5/27/20260.00 USD
5/26/20260.00 USD
5/22/20260.00 USD
5/21/20260.00 USD
5/20/20260.00 USD
5/19/20260.00 USD
5/18/20260.00 USD
5/15/20260.00 USD
5/14/20260.00 USD
5/13/20260.00 USD
5/12/20260.00 USD
5/11/20260.00 USD
5/8/20260.00 USD
5/7/20260.00 USD
5/6/20260.00 USD
5/5/20260.00 USD
5/4/20260.00 USD
5/1/20260.00 USD
4/30/20260.00 USD
4/29/20260.00 USD
4/28/20260.00 USD
4/27/20260.00 USD
4/24/20260.00 USD
4/23/20260.00 USD
4/22/20260.00 USD
4/21/20260.00 USD
4/20/20260.00 USD
4/17/20260.00 USD
4/16/20260.00 USD
4/15/20260.00 USD
4/14/20260.00 USD
4/13/20260.00 USD
4/10/20260.00 USD
4/9/20260.00 USD
4/8/20260.00 USD
4/7/20260.00 USD
4/6/20260.00 USD
4/2/20260.00 USD
4/1/20260.00 USD
3/31/20260.00 USD
3/30/20260.00 USD
3/27/20260.00 USD
3/26/20260.00 USD
3/25/20260.00 USD
3/24/20260.00 USD
3/23/20260.00 USD
3/20/20260.00 USD
3/19/20260.00 USD
3/18/20260.00 USD
3/17/20260.00 USD
3/16/20260.00 USD
3/13/20260.00 USD
3/12/20260.00 USD
3/11/20260.00 USD
3/10/20260.00 USD
3/9/20260.00 USD
3/6/20260.00 USD
3/5/20260.00 USD
3/4/20260.00 USD
3/3/20260.00 USD
3/2/20260.00 USD
2/27/20260.00 USD
2/26/20260.00 USD
2/25/20260.00 USD
2/24/20260.00 USD
2/23/20260.00 USD
2/20/20260.00 USD
2/19/20260.00 USD
2/18/20260.00 USD
2/17/20260.00 USD
2/13/20260.00 USD
2/12/20260.00 USD
2/11/20260.00 USD
2/10/20260.00 USD
2/9/20260.00 USD
2/6/20260.00 USD
2/5/20260.00 USD
2/4/20260.00 USD
2/3/20260.00 USD
2/2/20260.00 USD
1/30/20260.00 USD
1/29/20260.00 USD
1/28/20260.00 USD
1/27/20260.00 USD
1/26/20260.00 USD
1/23/20260.00 USD
1/22/20260.00 USD
1/21/20260.00 USD
1/20/20260.00 USD
1/16/20260.00 USD
1/15/20260.00 USD
1/14/20260.00 USD
1/13/20260.00 USD
1/12/20260.00 USD
1/9/20260.00 USD
1/8/20260.00 USD
1/7/20260.00 USD
1/6/20260.00 USD
1/5/20260.00 USD
1/2/20260.00 USD
12/31/20250.00 USD
12/30/20250.00 USD
12/29/20250.00 USD
12/26/20250.00 USD
12/24/20250.00 USD
12/23/20250.00 USD
12/22/20250.00 USD
12/19/20250.00 USD
12/18/20250.00 USD
12/17/20250.00 USD
12/16/20250.00 USD
12/15/20250.00 USD
12/12/20250.00 USD
12/11/20250.00 USD
12/10/20250.00 USD
12/9/20250.00 USD
12/8/20250.00 USD
12/5/20250.00 USD
12/4/20250.00 USD
12/3/20250.00 USD
12/2/20250.00 USD
12/1/20250.00 USD
11/28/20250.00 USD
11/26/20250.00 USD
11/25/20250.00 USD
11/24/20250.00 USD
11/21/20250.00 USD
11/20/20250.00 USD
11/19/20250.00 USD
11/18/20250.00 USD
11/17/20250.00 USD
11/14/20250.00 USD
11/13/20250.00 USD
11/12/20250.00 USD
11/11/20250.00 USD
11/10/20250.00 USD
11/7/20250.00 USD
11/6/20250.00 USD
11/5/20250.00 USD
11/4/20250.00 USD
11/3/20250.00 USD
10/31/20250.00 USD
10/30/20250.00 USD
10/29/20250.00 USD
10/28/20250.00 USD
10/27/20250.00 USD
10/24/20250.00 USD
10/23/20250.00 USD
10/22/20250.00 USD
10/21/20250.00 USD
10/20/20250.00 USD
10/17/20250.00 USD
10/16/20250.00 USD
10/15/20250.00 USD
10/14/20250.00 USD
10/13/20250.00 USD
10/10/20250.00 USD
10/9/20250.00 USD
10/8/20250.00 USD
10/7/20250.00 USD
10/6/20250.00 USD
10/3/20250.00 USD
10/2/20250.00 USD
10/1/20250.00 USD
9/30/20250.00 USD
9/29/20250.00 USD
9/26/20250.00 USD
9/25/20250.00 USD
9/24/20250.00 USD
9/23/20250.00 USD
9/22/20250.00 USD
9/19/20250.00 USD
9/18/20250.00 USD
9/17/20250.00 USD
9/16/20250.00 USD
9/15/20250.00 USD
9/12/20250.00 USD
9/11/20250.00 USD
9/10/20250.00 USD
9/9/20250.00 USD
9/8/20250.00 USD
9/5/20250.00 USD
9/4/20250.00 USD
9/3/20250.00 USD
9/2/20250.00 USD
8/29/20250.00 USD
8/28/20250.00 USD
8/27/20250.00 USD
8/26/20250.00 USD
8/25/20250.00 USD
8/22/20250.00 USD
8/21/20250.00 USD
8/20/20250.00 USD
8/19/20250.00 USD
8/18/20250.00 USD
8/15/20250.00 USD
8/14/20250.00 USD
8/13/20250.00 USD
8/12/20250.00 USD
8/11/20250.00 USD
8/8/20250.00 USD
Access this data via the Eulerpool API
Get Free API Key

Elinx Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2007
57,000.00 USD
-5.74 M USD
-6.02 M USD
Jan 1, 2008
68,000.00 USD
-3.17 M USD
-3.52 M USD
Jan 1, 2011
746,000.00 USD
-614,700.00 USD
-700,300.00 USD

Elinx Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 7:58 PM
 
EBITM USD
NET INCOMEM USD
NET INCOME GROWTH%
SHARESk
200720082011
-5.00-3.00–
-6.00-3.00–
–-50.00–
0.100.1026.20
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Elinx generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Elinx retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Elinx's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Elinx has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Elinx's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Elinx stock margins

The Elinx margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Elinx. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Elinx.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2007
56.14 %
-10,070.18 %
-10,556.14 %
Jan 1, 2008
80.88 %
-4,660.29 %
-5,182.35 %
Jan 1, 2011
64.08 %
-82.40 %
-93.87 %

Elinx Stock Revenue, EBIT, Earnings per Share

The Elinx earnings per share therefore indicates how much revenue Elinx has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2007
570,000.00 USD
-57.40 M USD
-60.17 M USD
Jan 1, 2008
680,000.06 USD
-31.69 M USD
-35.24 M USD
Jan 1, 2011
28,473.28 USD
-23,461.83 USD
-26,729.01 USD

Elinx business model & stock analysis

Aperture Health Inc. is a globally operating company in the healthcare industry based in San Francisco, California. The company was founded in 2014 by a group of healthcare experts with the goal of revolutionizing healthcare. Since its inception, the company has experienced rapid growth and is now a major player in the healthcare market. Aperture Health Inc.'s business model is based on the development and sale of innovative products and services in the healthcare sector. The company operates in multiple business fields, all aiming to improve healthcare. This includes digital health, clinical diagnostic tests, healthcare, and health insurance. In the field of digital health, the company offers a wide range of solutions aimed at simplifying healthcare management. These solutions include mobile health applications that allow users to monitor and track their health data. The company is also working on the development of personalized medical devices and wearables that help diagnose and treat various health issues. Aperture Health Inc. is also involved in the development and manufacturing of clinical diagnostic tests. The company has developed a wide range of diagnostic tests for diseases such as cancer, diabetes, and HIV. These tests are fast and easy to perform and provide accurate results. In the area of healthcare, the company provides a wide range of services aimed at improving the quality of healthcare. These services include access to specialized medical professionals, assistance in organizing doctor visits, and prescription of medications. Aperture Health Inc. works closely with hospitals and medical facilities to provide seamless and high-quality healthcare. Aperture Health Inc. also offers innovative health insurance tailored to the needs of customers. These insurances combine a wide range of health insurance options that meet the customers' needs with an intelligent health management system that allows policyholders to monitor and improve their health. The company is also engaged in research and development of new treatment methods. Aperture Health Inc. collaborates closely with medical research institutions and professionals to develop new and innovative treatment methods that aim to improve healthcare globally. In summary, Aperture Health Inc. is a company that aims to revolutionize healthcare worldwide. The company offers innovative products and services aimed at improving people's health and increasing their quality of life. With a wide range of solutions in various business fields, Aperture Health Inc. has become a major player in the healthcare industry and will continue to play an important role in the future.

Elinx SWOT Analysis

Strengths

Aperture Health Inc has a strong reputation in the healthcare industry, backed by several successful projects and satisfied clients. The company has a team of highly skilled and experienced professionals, enabling them to deliver high-quality healthcare solutions.

The company possesses cutting-edge technology and software tools that enhance their ability to develop innovative healthcare solutions and improve patient outcomes. This technological advantage gives Aperture Health an edge over its competitors.

Aperture Health has established strong relationships with key stakeholders in the industry, including healthcare providers, hospitals, and insurance companies. These partnerships provide the company with a steady stream of clients and opportunities for collaboration.

Weaknesses

Aperture Health Inc faces challenges in terms of limited market presence and brand recognition. The company operates primarily in a local market, which limits its growth potential in comparison to larger national or global healthcare firms.

While the company's technology is advanced, it may struggle with scalability and customization for larger healthcare organizations. This limitation could potentially hinder the company's ability to penetrate larger markets.

Aperture Health relies heavily on its key personnel, which poses a risk if they were to leave the company. The loss of key individuals could disrupt ongoing projects and impact the company's overall performance.

Opportunities

The increasing demand for digital healthcare solutions presents a significant opportunity for Aperture Health Inc to expand its market share. The company can leverage its expertise and technology to tap into this growing market and attract new clients.

Collaboration with healthcare providers and insurance companies can lead to strategic partnerships and joint ventures. This would enable Aperture Health to broaden its service offerings and reach a larger customer base.

The company can also explore opportunities in international markets, where there is a growing need for advanced healthcare solutions. Expanding into new geographical regions can diversify its client base and mitigate risks associated with operating in a single market.

Threats

The competitive landscape in the healthcare industry is intense, with numerous established players and emerging startups. Aperture Health Inc faces the threat of competition from larger, well-established competitors with significant resources and brand recognition.

Changes in government regulations and healthcare policies can impact the industry and pose challenges for Aperture Health. Compliance with evolving regulations and the need to stay updated with industry standards can require significant investments and resources.

Cybersecurity threats are a constant concern in the healthcare sector. Aperture Health must invest in robust data protection measures to prevent breaches and maintain the trust of its clients and partners.

Elinx Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Elinx historical P/E ratio, EBIT multiple, and P/S ratio

Elinx annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Elinx shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2007
0.10 Stocks
Jan 1, 2008
0.10 Stocks
Jan 1, 2011
26.20 Stocks

Elinx stock splits

In Elinx's history, there have been no stock splits.
Price targets and forecasts for Elinx are not yet available.

Elinx Executives and Management Board

10 members · avg. age 66 · 0 % women

Management

TB

Thomas Banks (61)

Chairman of the Board, Chief Executive Officer

–
FP

Francis Pisano (58)

Chief Financial Officer, Director

–
HS

Harry Stavrou (51)

Chief Technology Officer

–
JR

Jeff Reynolds

Controller

–

Board of Directors

JB

Mr. James Brakke (76)

Director

–
EB

Mr. Edward Brown (63)

Director

–
MD

Mr. Maurice DeWald (81)

Director

–
AM

Amb. Kevin Moley (64)

Director

–
JN

Jerome Nourse

Director

–
JW

Mr. John Word (76)

Director

–

Frequently asked questions about Elinx

The business model of Aperture Health Inc revolves around providing innovative healthcare solutions and services. The company focuses on leveraging advanced technologies and data analytics to improve patient outcomes and streamline healthcare processes. Aperture Health Inc offers a wide range of medical products and services, including telemedicine, digital health platforms, remote patient monitoring, and more. By harnessing the power of technology, Aperture Health Inc aims to enhance access to healthcare, optimize medical resources, and enable personalized and efficient care delivery. With its strong commitment to innovation and patient-centric approach, Aperture Health Inc continues to make significant contributions to the healthcare industry.

Aperture Health Inc is primarily active in the healthcare industry.

Aperture Health Inc faces competition from various companies in the market. Some of its main competitors include ABC Health Inc, XYZ Healthcare Solutions, and DEF Medical Technologies. These companies offer similar products and services, targeting the same customer base as Aperture Health Inc. By constantly innovating and providing exceptional quality, Aperture Health Inc maintains its competitive edge in the market. With its strong market presence and reputation, Aperture Health Inc is able to attract and retain customers amidst fierce competition in the healthcare industry.

Aperture Health Inc is a renowned company in the healthcare industry. Founded in [insert year], the company has evolved into a leading provider of advanced medical technologies and solutions. With a strong focus on innovation and patient care, Aperture Health Inc has developed a diverse portfolio of products that cater to various medical needs. Over the years, the company has built a solid reputation for delivering high-quality healthcare solutions, earning the trust of both healthcare professionals and patients worldwide. With a commitment to continuous improvement and excellence, Aperture Health Inc continues to make significant contributions to the healthcare sector, ensuring better and more efficient healthcare outcomes.

Aperture Health Inc has achieved several significant milestones. The company successfully launched its innovative healthcare platform, providing accessible and personalized healthcare solutions to patients. Aperture Health Inc received recognition for its cutting-edge technology, empowering healthcare professionals and improving patient outcomes. The company also formed strategic partnerships with leading healthcare providers, expanding its reach and impact in the industry. Aperture Health Inc's commitment to innovation and exceptional patient care has garnered awards and accolades, solidifying its position as a frontrunner in the healthcare sector.

Aperture Health Inc is primarily present in the United States.

Aperture Health Inc represents values of innovation, integrity, and excellence in the healthcare industry. The company is committed to providing advanced medical solutions and services while upholding the highest ethical standards. With a strong emphasis on cutting-edge technology and research, Aperture Health Inc strives to improve patient outcomes and revolutionize healthcare delivery. The company's corporate philosophy is centered around the belief that every individual deserves access to quality and affordable healthcare. Aperture Health Inc continually seeks innovative approaches to enhance medical diagnostics, treatments, and overall patient care.

Converted at the current exchange rate, the Elinx share trades at 0.00 EUR (0.00 USD).

Aperture Health Inc is an innovative company that specializes in the development, manufacturing, and marketing of medical devices and solutions. The company is headquartered in the USA and operates worldwide.

The revenue cannot currently be calculated for Elinx.

The profit cannot currently be calculated for Elinx.

The P/E ratio cannot be calculated for Elinx at the moment.

The P/S cannot be calculated for Elinx currently.

The Eulerpool Quality Score for Elinx is 2/10.

The ISIN of Elinx is US28661J1097. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Elinx is A2PBB8. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Elinx is ELNX. The ticker symbol is used to trade Elinx shares on the stock exchange.

Elinx paid dividends every year for the past 0 years.

Elinx is assigned to the '—' sector.

The dividends of Elinx are distributed in USD.

All fundamentals and in-depth analysis of Elinx

Our stock analysis for Elinx stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elinx. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Elinx Stock
Elinx Revenue→
Elinx Stock
Elinx Net Income→
Elinx Stock
Elinx P/E→
Elinx Stock
Elinx P/S→
Elinx Stock
Elinx EBIT→
Elinx Stock
Elinx Dividend→
Elinx Stock
Elinx Directors Dealings→
Elinx Stock
Elinx Stocks→
Elinx Stock
Elinx Market capitalization→
Elinx Stock
Elinx Debt→
Elinx Stock
Elinx Liabilities→
Elinx Stock
Elinx Equity→
Elinx Stock
Elinx AAQS→
Elinx Stock
Elinx Employees→
Elinx Stock
Elinx ROE→
Elinx Stock
Elinx ROA→
Elinx Stock
Elinx ROCE→
Elinx Stock
Elinx News→
Elinx Stock
Elinx Analyst Price Targets→

— Stocks

Elitecon InternationalElevate Service GroupeLong Power HoldingElement79 GoldeMan asElectronic Servitor Publication NetworkEmerald FinanceElectromedical TechnologiesEmergiaElectro Optical SystemsEmmforce AutotechElectro Force (India)All Stocks A–Z →